India pressed to relax rules on clinical trials. Drug companies claim changes are essential, but critics fear Indian patients will become guinea pigs.
In: Lancet, Jg. 363 (2004-05-08), Heft 9420, S. 1528-1529
Online
academicJournal
Zugriff:
Discusses how pharmaceutical companies in India are pressuring the Indian government to relax regulations governing clinical trial. How more lax regulations will enable companies to capture lucrative outsourcing contracts from European and North American companies, and boost India's research and development capacity; Advantages offered by India for companies interested in conducting clinical trials; Description of the drug industry in India; Details of the current restrictions; Concerns the abuse of patients in clinical trials.
| Titel: |
India pressed to relax rules on clinical trials. Drug companies claim changes are essential, but critics fear Indian patients will become guinea pigs.
|
|---|---|
| Autor/in / Beteiligte Person: | Sharma, Dinesh C. |
| Link: | |
| Zeitschrift: | Lancet, Jg. 363 (2004-05-08), Heft 9420, S. 1528-1529 |
| Veröffentlichung: | 2004 |
| Medientyp: | academicJournal |
| ISSN: | 0140-6736 (print) |
| DOI: | 10.1016/S0140-6736(04)16186-2 |
| Schlagwort: |
|
| Sonstiges: |
|